Arcutis Biotherapeutics Inc

Stock Chart, Company Information, and Scan Results

$23.49(as of May 4, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Arcutis Biotherapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$23.49
Ticker SymbolARQT
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees354
CountyUSA
Market Cap$2,920.5M

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Arcutis Biotherapeutics Inc In Our Stock Scanner

As of May 05, 2026
As of ---
As of ---
As of ---
As of ---
example chart graphic
Scan Name: Double BottomScan Type: Chart Pattern Scans
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.